Recipharm named Vikas Gupta as President of its recently renamed biologics business arm. Gupta joins ReciBioPharm from Repligen, where he was Vice President & General Manager, Gene Therapy and Downstream Bioprocessing. The appointment comes as Recipharm officially renames its biologics business division after the acquisitions of Arranta Bio, GenIbet and Vibalogics.
1st Jan change | Capi. | |
---|---|---|
+5.90% | 71.83B | |
+22.78% | 9.56B | |
+30.09% | 4.85B | |
-21.31% | 4.48B | |
+24.78% | 3.9B | |
+11.03% | 2.01B | |
-2.11% | 1.99B | |
-36.28% | 1.89B | |
-43.19% | 1.77B |